Ilika plc with ticker (LON:IKA) now has a potential upside of 227.9% according to Berenberg Bank.
Berenberg Bank set a target price of 100 GBX for the company, which when compared to the Ilika plc share price of 31 GBX at opening today (26/04/2024) indicates a potential upside of 227.9%. Trading has ranged between 25 (52 week low) and 60 (52 week high) with an average of 221,915 shares exchanging hands daily. The market capitalisation at the time of writing is £49,282,436.
Ilika plc is a United Kingdom-based company. The Company is engaged in developing and commercializing its cutting-edge solid-state batteries. The Company develops and commercializes its thin-film Stereax miniature solid-state batteries for powering implantable medical devices and industrial wireless sensors (IIoT) in specialist environments, as well as progressing the development of its large-format Goliath cells for electric vehicles (EV) and cordless appliances. It has a secured lease of approximately 1,600 square meters property for Stereax manufacturing scale-up and installed over 340 square meters clean room facility. The Company is enabling solutions for applications, such as industrial Internet of things (IoT), MedTech, electric vehicles (EV) and consumer electronics. The Company has its operations in the United States of America, China and Israel.
Ilika plc 227.9% potential upside indicated by Berenberg Bank
- Written by: Charlotte Edwards
Find more news, interviews, share price & company profile here for:
Latest Company News
Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.
Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets.
Ilika will present its UK-developed quasi-solid-state cell technology at the Faraday Institution Conference 2026 in Nottingham, placing its Goliath programme within a major energy storage innovation forum.
Ilika’s latest Cavendish note highlights fresh funding to support Stereax commercialisation and Goliath development across medical, defence and e-bike markets.
Defence applications are increasing the need for safer, lighter and more reliable battery technology.
Ilika has conditionally raised approximately £4.56 million through an oversubscribed placing and subscription, with proceeds to support the commercialisation of its Stereax and Goliath solid-state battery technologies.
